MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products... Show more
MetLife operates as a leading global provider of insurance, annuities, and employee benefits, with core strengths in group benefits, retirement and income solutions, asset management, and select international markets. The company holds leading positions in several segments, supported by substantial technology investments that have grown faster than the broader market since 2019. Its diversified business model provides resilience, while a focus on efficiency and customer-centric innovation supports medium-term competitive advantages. Structural positioning emphasizes disciplined capital allocation, balancing reinvestment in high-growth areas with shareholder returns through dividends and buybacks.
The next earnings release, scheduled for August 5, 2026, will provide updated visibility into execution of the New Frontier plan and could influence sentiment based on progress toward double-digit EPS growth and free cash flow targets. Continued capital deployment, including share repurchases and dividend increases, remains a focal point for income-oriented investors. Strategic expansions in international markets and enhancements to retirement and asset management offerings represent potential growth drivers. Analyst expectations have shown modest upward revisions to 2026 EPS estimates recently, maintaining a generally constructive stance with an attractive forward price-to-earnings multiple relative to peers. Regulatory developments in insurance and financial services could also emerge as catalysts depending on policy direction.
The life and health insurance industry faces evolving demand patterns tied to demographic shifts, workplace benefits trends, and retirement planning needs. Interest rate environments directly impact MetLife’s investment portfolio yields and the attractiveness of its annuity and retirement products. Inflation and broader economic conditions influence premium growth, claims experience, and consumer spending on financial protection. Geopolitical factors and regulatory climates in key international markets add layers of complexity, while accelerating technology adoption in insurance distribution and risk assessment supports efficiency gains across the sector. These forces collectively shape MetLife’s ability to sustain margins and expand its addressable market.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. It is designed to help users spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments. The product includes searchable prediction categories, historical context, and alert-oriented functionality. Trend Prediction Engine
Looking to 2026 and beyond, MetLife’s trajectory centers on sustained execution of the New Frontier strategy, with emphasis on market expansion in group benefits and international segments, ongoing cost-structure optimization, and technology-driven product enhancements. Margin sustainability will depend on investment income stability and disciplined underwriting amid shifting interest rate and inflation dynamics. Long-term themes include potential growth in retirement solutions driven by aging populations, competitive pressures from fintech and traditional insurers, and regulatory developments affecting capital requirements. Consensus analyst expectations for continued EPS expansion reflect confidence in the company’s diversified model and capital generation capabilities, though outcomes will hinge on successful navigation of macroeconomic conditions and strategic priorities through the remainder of the five-year plan.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a provider of insurance and financial services and also function as bank holding company
Industry LifeHealthInsurance
A.I.dvisor indicates that over the last year, MET has been closely correlated with PRU. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if MET jumps, then PRU could also see price increases.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MET advanced for three days, in of 344 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on August 12, 2026. You may want to consider a long position or call options on MET as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 276 cases where MET Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for MET moved out of overbought territory on August 07, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 69 cases where MET's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for MET turned negative on August 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MET declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
MET broke above its upper Bollinger Band on August 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. MET’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 62, placing this stock better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.257) is normal, around the industry mean (1.437). P/E Ratio (18.672) is within average values for comparable stocks, (20.901). Projected Growth (PEG Ratio) (0.542) is also within normal values, averaging (1.307). Dividend Yield (0.024) settles around the average of (0.045) among similar stocks. P/S Ratio (0.826) is also within normal values, averaging (1.321).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.